£325.00

It has never been this cheap. We have no record of a lower price.

£325 today · cheaper than every other day in the last 3 months

HPV Testing Outlook 2013-2018 - North America & Caribbean

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days · 91 data points

Historical
Generating forecast…
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 03 August 2026 25 August 2026 17 September 2026 09 October 2026 01 November 2026
View at Amazon ↗

Price data updated today

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 91 days • 1 price levels

Days at Price
91 days 0 23 46 68 91 £325 Days at Price

Price Analysis

Most common price: £325 (91 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 91 days

Description

This econometric study provides a comprehensive outlook for human papilloma virus (HPV) testing across North America and the Caribbean. Using advanced econometric models that project fundamental economic dynamics, the report offers detailed estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars for each country. Readers can access comparative benchmarks to gauge a country's market position relative to others in the region and the globe. By analyzing percent shares and economic projections, this report serves as a specialized resource for understanding market potential and economic trends within the HPV testing sector.

Key Features

Covers the outlook for human papilloma virus (HPV) testing in North America and the Caribbean from 2013 to 2018.

Provides estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year.

Includes comparative benchmarks showing the percent share of each country relative to both the region and the globe.

Utilizes econometric models to project fundamental economic dynamics within and across specific countries.

Offers detailed data for gauging individual country performance against regional and global market trends.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
25 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in the United States
99% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in the United States

£495.00 31 Oct 2026
HPV Testing in Latin America 2013-2018 Econometric Study
99% match

HPV Testing in Latin America 2013-2018 Econometric Study

£325.00 31 Oct 2026
The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in India
99% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in India

£495.00 28 Oct 2026
HPV Testing in Europe 2013-2018 Econometric Outlook Report
99% match

HPV Testing in Europe 2013-2018 Econometric Outlook Report

£325.00 01 Nov 2026
The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Japan
99% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Japan

£495.00 30 Oct 2026
The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Greater China
99% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in Greater China

£495.00 29 Oct 2026
HPV Testing in Africa 2013-2018 Econometric Outlook Study
99% match

HPV Testing in Africa 2013-2018 Econometric Outlook Study

£325.00 31 Oct 2026
The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in The Middle East
99% match

The 2013-2018 Outlook for Human Papilloma Virus (HPV) Testing in The Middle East

£325.00 28 Oct 2026
The 2021-2026 World Outlook for Human Papillomavirus (HPV) Testing
98% match

The 2021-2026 World Outlook for Human Papillomavirus (HPV) Testing

£795.00 15 Sep 2026
The 2021-2026 World Outlook for Human Papillomavirus (HPV) and Pap Testing
98% match

The 2021-2026 World Outlook for Human Papillomavirus (HPV) and Pap Testing

£795.00 15 Sep 2026
The 2023-2028 Outlook for HPV Vaccines in Japan
98% match

The 2023-2028 Outlook for HPV Vaccines in Japan

£495.00 29 Oct 2026
The 2023-2028 Outlook for HPV Vaccines in the United States
98% match

The 2023-2028 Outlook for HPV Vaccines in the United States

£520.00 15 Aug 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in China
98% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in China

£495.00 29 Oct 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in Japan
98% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in Japan

£495.00 30 Oct 2026
HPV and CMV Therapeutics Outlook 2023-2028 US Zip Codes
97% match

HPV and CMV Therapeutics Outlook 2023-2028 US Zip Codes

£490.00 27 Aug 2026
The 2023-2028 Outlook for Human Papillomavirus Vaccines in Japan
97% match

The 2023-2028 Outlook for Human Papillomavirus Vaccines in Japan

£495.00 15 Aug 2026
The 2023-2028 Outlook for Human Papillomavirus Vaccines in China
97% match

The 2023-2028 Outlook for Human Papillomavirus Vaccines in China

£495.00 01 Nov 2026
The 2026-2031 World Outlook for HPV and CMV Therapeutics
97% match

The 2026-2031 World Outlook for HPV and CMV Therapeutics

£885.00 03 Oct 2026
The 2023-2028 Outlook for Human Papillomavirus Vaccines in the United States
97% match

The 2023-2028 Outlook for Human Papillomavirus Vaccines in the United States

£520.00 15 Aug 2026
The 2023-2028 Outlook for Human Papillomavirus Vaccines in India
97% match

The 2023-2028 Outlook for Human Papillomavirus Vaccines in India

£515.00 28 Oct 2026
Pap Smear Tests Cervical Cancer Outlook 2023-2028 Study
97% match

Pap Smear Tests Cervical Cancer Outlook 2023-2028 Study

£490.00 05 Sep 2026
HPV Vaccine Latent Demand Outlook 2023-2028 by US Zip Code
97% match

HPV Vaccine Latent Demand Outlook 2023-2028 by US Zip Code

£490.00 28 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026